Related Experiment Videos
Disease recurrence following liver transplantation
J Hart1, R W Busuttil, K J Lewin
1Department of Pathology, UCLA School of Medicine, 90024.
The American Journal of Surgical Pathology
|January 1, 1990
Summary
Disease recurrence after liver transplantation is a significant concern. Hepatitis B recurrence was high (79%), and 46% of hepatocellular carcinoma patients experienced tumor recurrence, highlighting critical post-transplant challenges.
Area of Science:
- Hepatology
- Transplantation Medicine
- Immunology
Background:
- Disease recurrence post-liver transplantation is a growing clinical issue.
- Understanding recurrence patterns is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the incidence and patterns of recurrence for hepatitis B, hepatitis non-A, non-B (NANB), primary biliary cirrhosis (PBC), and malignancy following liver transplantation.
Main Methods:
- Retrospective analysis of 106 liver transplant patients.
- Evaluation of histologic evidence and clinical data for disease recurrence.
- Assessment of treatment efficacy (vaccine, immunoglobulin, chemotherapy).
Main Results:
- Hepatitis B recurrence observed in 79% of eligible patients, with progression to cirrhosis in two.
- Hepatitis B treatments were ineffective in preventing recurrence.
- Hepatocellular carcinoma recurrence occurred in 46% of patients, with significant mortality.
- Hepatitis NANB recurrence was low (2/23), and PBC recurrence was not definitively diagnosed due to limited follow-up.
Conclusions:
- Hepatitis B recurrence is frequent and difficult to prevent post-transplant.
- Hepatocellular carcinoma recurrence poses a substantial threat to long-term survival.
- Further research is needed to define the role of chemotherapy and optimize management strategies for recurrent diseases.